TR-A771278 - Arimoclomol (289893-25-0)
Sorry, no product with reference TR-A771278has been found, but please check out the following similar products:
See more![discount label](https://static.cymitquimica.com/public/img/discount.png)
Arimoclomol
CAS:289893-25-0
Formula:
C14H20ClN3O3
Purity:
≥ 98.0%
Color and Shape:
White to off-white powder
Molecular weight:
313.78
Ref: 7W-GP7277
Undefined size | To inquire |
Estimated delivery in United States, on Tuesday 4 Mar 2025
![discount label](https://static.cymitquimica.com/public/img/discount.png)
Arimoclomol
CAS:289893-25-0
Arimoclomol (BRX-220 free base) is a co-inducer of heat shock proteins (HSP) and can be …
Formula:
C14H20ClN3O3
Purity:
99.81%
Color and Shape:
Solid
Molecular weight:
313.78
- Inhibitors
- HSP
- Proteasome
- Cytoskeletal Signaling
- See more categories
- Arimoclomol and Impurities
Ref: TM-T13553
1mg | 115.00 € | ||
5mg | 249.00 € | ||
10mg | 369.00 € | ||
25mg | 562.00 € | ||
50mg | 787.00 € | ||
100mg | 1,054.00 € | ||
200mg | 1,406.00 € | ||
1mL*10mM (DMSO) | 249.00 € |
Estimated delivery in United States, on Monday 21 Apr 2025
![discount label](https://static.cymitquimica.com/public/img/discount.png)
(2R-)Arimoclomol
CAS:289893-25-0
A co-inducer of HSP that acts through heat shock factor 1 (HSF1) in cells undergoing …
Formula:
C14H20ClN3O3
Purity:
Min. 95%
Color and Shape:
White Powder
Molecular weight:
313.78 g/mol
Ref: 3D-FA30834
25mg | 384.00 € | ||
50mg | 585.00 € | ||
100mg | 931.00 € | ||
250mg | 1,942.00 € | ||
500mg | 3,508.00 € |
Estimated delivery in United States, on Wednesday 12 Mar 2025
![discount label](https://static.cymitquimica.com/public/img/discount.png)
3-Pyridinecarboximidoyl chloride, N-[(2R)-2-hydroxy-3-(1-piperidinyl)propoxy]-, 1-oxide
CAS:289893-25-0
Formula:
C14H20ClN3O3
Purity:
95%
Color and Shape:
Liquid
Molecular weight:
313.7799
Ref: IN-DA002V3O
1mg | 159.00 € | ||
5mg | 476.00 € | ||
10mg | 498.00 € | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire | ||
200mg | To inquire |
Estimated delivery in United States, on Monday 3 Mar 2025